ABSTRACT
Objectives:Esophageal cancer is a poorly characterized deadly cancer with a malignancy ratio of 2/3 among Iranian males and females, respectively. Recent studies on miR-520c and miR-519d have evidenced their either oncogenic or tumor suppressing roles in different cancers. The goal of this study was to assay the altered expressions of miR-520c and miR-519d in esophageal tumor tissues and adjacent non-tumor tissues in patients suffering from esophageal cancer.
Methods:RNA was extracted from 36-pair paraffin-embedded tumor and adjacent non-tumor tissues using TRIZOL kit and relative expressions of miR-520c and miR-519d were quantified by Real Time and RT-PCR using specific predesigned primers. CT method (2-ΔΔCT) and SPSS16 were used for statistical calculations.
Results:Statistical analysis has revealed spectacular upward expression increases of 10.4 and 24.5 folds of miR-520c and miR-519d adjacent in Esophageal Squamous Cells compared to their non-tumor tissues (P <0.05).
Conclusion:In general, the present study being the first report on the evaluation of miR-520c and miR-519d expressions in ESCC, is able to highlight the oncogenic roles of the two miRNA in ESCC and introduce them as appropriate potential alternatives to be utilized for further research on clinical treatment.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.